Showing posts with label NeuroOncology. Show all posts
Showing posts with label NeuroOncology. Show all posts

Mehta: Principles & Practice of Neuro-oncology: A Multidisciplinary Approach

Neuro-oncologic (brain and spine) cancers account for 19,000 new cases and 13,000 deaths per year. The early and proper diagnosis of these virulent cancers is critical to patient outcomes and diagnosis and treatment strategies are continually evolving. The multidisciplinary team that manages these patients involves medical radiation oncology, neurosurgery, molecular biology, neuroimaging, nurses and therapists. Principles and Practices of Neuro-Oncology establishes a new gold standard in care through a comprehensive, multidisciplinary text covering all aspects of neuro-oncology. Six major sections cover all topics related to epidemiology and etiology, clinical features and supportive care, imaging, neuroanatomy and neurosurgery, medical oncology and targeted therapies, and radiation oncology for adult and pediatric cancers.

Expert contributors from multiple disciplines provide detailed and in-depth discussions of the the entire field of neuro-oncology including histopathologic harmonization, quality of life amd therapeutic changes in terms of combined modality treatments, the advent of new drugs, especially targeted agents, and the tantalizing early promise of personalized therapeutic approaches.

With contributions from over 180 authors, numerous diagrams, illustrations and tables, and a 48-page color plate section, Principles and Practice of Neuro-Oncology reflects the breadth and depth of this multi-faceted specialty.


About the Author
  • Minesh Mehta, MD, FASTRO, Professor, Department of Human Oncology, University of Wisconsin, Madison, Wisconsin. 
  • Susan Chang, MD, Professor, Vice Chair, Neurological Surgery, Director, Division of Neuro-Oncology, University of California San Francisco, San Francisco, California. 
  • Herbert Newton, MD, FAAN, Professor of Neurology, Neurosurgery, and Oncology, Esther Dardinger Endowed Chair in Neuro-Oncology, Department of Neurosurgery, Dardinger Neuro-Oncology Center, The Ohio State University Medical Center, James Cancer Hospital, Columbus, Ohio. 
  • Abhijit Guha, MSc, MD, FRCSC, FACS, Professor of Surgery (Neurosurgery), Toronto Western Hospital, Senior Scientist and Co-Director, The Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children, Hudson Chair in Neuro-Oncology, Department of Surgery (Neurosurgery), University of Toronto, Toronto, Ontario, Canada. 
  • Michael Vogelbaum, MD, PhD, FACS, Robert and Kathryn Lamborn Chair for Neuro-Oncology, Associate Director of Neurosurgical Oncology, Department of Neurosurgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio.


Book Details

  • Hardcover: 1048 pages
  • Publisher: Demos Medical Publishing; 1 edition (October 22, 2010)
  • Language: English
  • ISBN-10: 1933864788
  • ISBN-13: 978-1933864785
  • Product Dimensions: 11.1 x 8.5 x 1.9 inches
List Price: $245.00 
 

Pediatric CNS Tumors 2nd Edition (Springer) 2010

Pediatric brain tumors are a tremendous challenge for the treating physician. Their diverse biological behaviors, in the unique context of the developing nervous system, require fl exible and tailored treatment plans. In the last 20 years, there has been an exponential increase in our understanding of the molecular and genetic basis of human malignancy.
The goal of Pediatric CNS Tumors 2nd Edition is to provide a current, biologically-based perspective of the management of central nervous system tumors in children. Rather than present every tumor type in an encyclopedic manner, the common tumor types encountered in clinical practice are presented in the initial chapters.
The epidemiology, pathological features, clinical presentation, diagnosis, and treatment are discussed for each tumor type. We have separated high- and lowgrade glial tumors into separate chapters, mainly because the management and outcome for these two classes of tumors are very different. In the final chapters, many of the diagnostic and treatment modalities common to all tumors are discussed with an emphasis on emerging and experimental techniques. For the second edition, new chapters have been added: Rare Tumors (Chap. 11) and Late Effects and Palliative Care (Chap. 17). A valuable resource is the WHO classification of tumors of the central nervous system; the fourth edition of which was published in 2007 (Louis et al. 2007).
It is recognized that a variety of treatment strategies are utilized by many different practitioners and institutions. For the most part, the general management principles used at the University of California, San Francisco, are presented, usually in the context of standard therapy. Although this approach may underemphasize other equally valid approaches, we believe that the reader will benefi t from a coherent approach to the management of childhood tumors.

Contents
1 Low-Grade Gliomas
2 High-Grade Gliomas
3 Brainstem Gliomas
4 Ependymoma
5 Embryonal Tumors
6 Intracranial Germ-Cell Tumors
7 Craniopharyngioma
8 Neuronal Tumors
9 Choroid Plexus Tumors
10 Intramedullary Spinal Cord Tumors
11 Rare Tumors
12 Neurocutaneous Syndromes and Associated CNS Tumors
13 Modern Neuroimaging of Pediatric Brain Tumors
14 Current Surgical Management
15 Chemotherapy
16 Advances in Radiation Therapy
17 Late Effects of Treatment and Palliative Care
Subject Index

Tonn: Oncology of CNS Tumors 2nd Edition

Knowledge about the etiology and diagnosis as well as treatment concepts of neurooncologic diseases is rapidly growing. This turnover of knowledge makes it diffi cult for the physician engaged in the treatment to keep up to date with current therapies. This book sets out to close the gap and pursues several innovative concepts.
Sooner than expected, the first edition of this book has sold out. The fact that the book was so well received shows that there is a demand for a comprehensive, practice oriented textbook of neuro-oncology. This is all the more true today as there have been many more advances in the diagnosis and treatment of patients with brain tumors than in prior decades. A number of these advancements can be attributed to the use of translational medicine for which there is now good scientifi c rationale. For this reason a comprehensive revision of the fi rst edition had become necessary.

Brain Tumor Immunotherapy

Brain Tumor Immunotherapy by Linda M. Liau, Donald P. Becker, Timothy F. Cloughesy and Darell D. Bigner provide a comprehensive guide to modern brain tumor immunotherapy and thereby enhance future research in this area. The contributors detail many of the key laboratory experiments and clinical protocols that are currently being investigated, integrate the available information from previous and ongoing research, and help define the current status of the field. Topics range from adoptive cellular and antibody-mediated immunotherapy of brain tumors to tumor vaccines and related strategies, and include many vanguard experimental strategies and immunological techniques for studying brain tumor immunotherapy. Cutting-edge and comprehensive, Brain Tumor Immunotherapy brings together all the important recent advances in our understanding of central nervous system tumor immunology and illustrates in powerful detail the many new applications now harnessing the immune response for brain tumor therapeutics.


Book Info
Univ. of California, Los Angeles. Features emphasis on immunotherapy for central nervous system cancers. Reviews key ingredients needed for immune responses within the brain. Surveys heterogeneous pathobiology of brain tumors and challenges for immunotherapy, and provides current data on clinical immunotherapy trials. DNLM: Brain Neoplasms--therapy.


Book Details

  • Hardcover: 373 pages
  • Publisher: Humana Press; 1st edition (January 15, 2001)
  • Language: English
  • ISBN-10: 0896036383
  • ISBN-13: 9780896036383
  • Product Dimensions: 9.4 x 9.4 x 6.4 inches
List Price: $124.50 
 

Intracranial Tumors of the Central Nervous System

Intracranial Tumors of the Central Nervous System by Lisa M. DeAngelis, Philip H. Gutin, Steven A. Leibel and Jerome B. Posner is written by leading professionals in the field of neuro-oncology, this book provides a valuable overview and presentation of the most up-to-date ideas in the diagnosis, treatment, and management of intracranial tumors. Covering the recent diagnostic and therapeutic tools available in the radiological armanentarium, including MRI, stereotactic needle biopsy, functional MRI, 3D conformal radiotherapy (RT), radiosurgery, fractionated stereotactic RT, new chemotherapy agents and novel regimens, gene therapy, and anti-angiogenesis factors, and illustrated with quality images throughout, the book will be of great interest to all health professionals in this field.

Book Info
Memorial Sloan-Kettering Cancer Center, New York, NY. Covers the recent diagnostic and therapeutic tools available in the radiological armamentarium, including MRI, stereotactic needle biopsy, functional MRI, 3D conformal radiotherapy, radiosurgery, fractionated stereotactic RT, chemotherapy agents and novel regimens, gene therapy, and more.

Book Details
  • Hardcover: 420 pages
  • Publisher: Informa Healthcare; 1 edition (May 1, 2001)
  • Language: English
  • ISBN-10: 1901865371
  • ISBN-13: 9781901865370
  • Product Dimensions: 10.2 x 7.4 x 1.1 inches
  • List Price: $269.95
Buy Now

Handbook of Brain Tumor Chemotherapy

Handbook of Brain Tumor Chemotherapy by Herbert B. Newton reviews the state-of-the-art of chemotherapy development and clinical treatment of patients with this devastating disease. Handbook of Brain Tumor Chemotherapy offers a unique cutting-edge compendium of basic science and clinical information on the subject of brain tumor chemotherapy, reviewing what has been accomplished thus far and how the field will continue to evolve with the development of more specific and efficacious chemotherapeutic agents. This book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy.

Book features:
  • Provides the most up to date information regarding conventional forms of cytotoxic chemotherapy, as well as the basic science and clinical application of molecular therapeutics, for the treatment of brain tumors.
  • Broadly appeals to anyone interested in the field of Neuro-Oncology and in the treatment of patients with brain tumors.
  • Useful to clinicians interested in a thorough overview of the use of chemotherapy in patients with a broad range of brain tumors as well as serving as a source of background information to basic scientists and pharmaceutical researchers with an interest in the molecular therapeutics of brain tumors.
Book Details
  • Hardcover: 586 pages
  • Publisher: Academic Press; 1 edition (December 13, 2005)
  • Language: English
  • ISBN-10: 0120884100
  • ISBN-13: 9780120884100
  • Product Dimensions: 11 x 8.3 x 1.1 inches
  • List Price: $180.00
  • Price: $152.50
  • You Save: $27.50 (15%)
Buy Now

Brain Tumors: Leaving the Garden of Eden: A Survival Guide to Diagnosis, Learning the Basics, Getting Organized, and Finding Your Medical Team

Unlike most diseases where you go to your doctor and let him / her make all of the decisions, dealing with a brain tumor is very different. You will be dealing with up to 20 different types of health professionals. You will be given choices that your doctor doesn't even want to make for you. Decisions that you make can greatly affect your chances of being a long term survivor. You need all of the help you can get. This book was written by one of the best neuro-oncologists in the world, drawing not only on his professional experiences dealing with his own patients at some of the most prestigious brain tumor centers in the USA, but also on his many years of participating in online support groups and answering questions from my website, Clinical Trials And Noteworthy Treatments For Brain Tumors.
Brain Tumors:Leaving the Garden of Eden is a guidebook for over 150,000 people per year and families affected by brain tumors. This book will help you learn the basics about diagnosis, getting organized and finding your medical team. Included are chapters on all major types of brain tumors & metastases, glossary, medications, using the Internet to search for information, and getting a second opinion. It is all about improving your odds by gathering information, & assessing your situation: What you need to do; what you need to know; what you can do now!

About the Author
Paul Zeltzer MD is an expert and brain tumor specialist (Neurooncologist) for both children and adults. Thousands of loyal readers have received his thoughtful views on several websites and "chatrooms" via the Internet. He has 28 years experience as an academic oncologist and researcher at four leading University teaching hospitals. He is recognized particularly on subjects of immune therapies, alternative and complementary approaches and effects of the Internet on Healthcare. A sought-after speaker, he is frequently quoted on the Web and on broadcast media throughout the world. "Dr. Paul" is fluent in Spanish and English and has lectured worldwide. He has been an advisor to several hit television medical shows.

Book Details
  • Title: Brain Tumors: Leaving the Garden of Eden--A Survival Guide to Diagnosis, Learning the Basics, Getting Organized, and Finding Your Medical Team
  • Author: Paul M. Zeltzer
  • Paperback: 400 pages
  • Publisher: Shilysca Press; Ill Lgr edition (December 15, 2004)
  • Language: English
  • ISBN-10: 0976017105
  • ISBN-13: 9780976017103
  • Book Dimensions: 8.9 x 7.5 x 0.7 inches
  • List Price: $29.95
  • Amazon.com Price: $28.45
  • You Save: $1.50 (5%)
Buy Now

Brain Tumors (Contemporary Cancer Research)

This multi-authored textbook compiles recent scientific advances in brain-tumor biology. In the past 10 to 15 years, there has been an explosion of information regarding the genesis and pathological classification of and new treatments for brain tumors. The main focus of this book is the gliomas, but it also deals with other primary brain tumors, such as meningiomas, as well as brain metastases. The editor has called on a notable group of authors who are widely recognized as experts and investigators of the fundamental abnormalities that characterize malignant brain tumors.
The book has three sections. The first focuses on epidemiology, biology, genetics, and pathology; the second describes mechanisms and genetic pathways involved in oncogenesis; and the final section reviews new therapeutics. There is considerable overlap of information, particularly between the first two sections, in describing the critical pathways that are disrupted in glioma. For example, the molecular characteristics that distinguish a primary from a secondary glioblastoma are discussed many times. Nevertheless, this repetition enables each chapter to stand alone, freeing the reader from having to refer to prior material to follow an author's line of thought.
This book contains a welcome compilation of the known genetic abnormalities in malignant gliomas and is an excellent reference with a good description of each abnormality. Furthermore, many authors discuss the interaction of multiple abnormalities and how the interaction affects the survival of malignant cells. The book also takes up the full spectrum of brain-tumor biology. Thus, there are chapters describing overall immune regulation, how it works in the brain, and how it could be harnessed for the treatment of brain tumors.

Book Details
  • Title: Brain Tumors (Contemporary Cancer Research)
  • Editor: Francis Ali-Osman
  • Hardcover: 400 pages
  • Publisher: Humana Press; 1 edition (October 2003)
  • Language: English
  • ISBN-10: 1588290425
  • ISBN-13: 9781588290427
  • Book Dimensions: 10.2 x 7.2 x 1 inches
  • List Price: $150.00
  • Amazon.com Price: $136.50
  • You Save: $13.50 (9%)
Buy Now

Copyright 2010 Cancer Reviews Center - All Rights Reserved.
Designed by Web2feel.com | Bloggerized by Lasantha - Premiumbloggertemplates.com | Affordable HTML Templates from Herotemplates.com.